Pretreatment before in vitro fertilization and its effectiveness in patients with diffuse adenomyosis
- Autores: Aksenenko A.A.1, Gus A.I.1, Mishieva N.G.1, Senina D.N.1
-
Afiliações:
- Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
- Edição: Nº 7 (2021)
- Páginas: 113-120
- Seção: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/249399
- DOI: https://doi.org/10.18565/aig.2021.7.113-120
- ID: 249399
Citar
Texto integral
Acesso aberto
Acesso está concedido
Acesso é pago ou somente para assinantes
Resumo
Aim. To conduct preparatory treatment before in vitro fertilization (IVF) program and to assess its effectiveness in patients with various stages of adenomyosis. Materials and methods. The study included 198patients with infertility and ineffective past IVF attempts. They were examined and diagnosed with adenomyosis, that could be a possible cause of implantation failure in previous attempts of IVF. 128 patients were randomly divided into three groups. As a preparatory treatment before IVF program, the patients received adenomyosis treatment with GnRH-a, COC and Dienogest in a continuous mode for 3 months. 70patients did not undergo preparatory treatment before IVF program. Results. Stage I adenomyosis had no impact on the effectiveness of the IVF program and did not require pretreatment. At stages II-III adenomyosis, preparatory treatment may increase the conception rate. However, the incidence of pregnancy in women with stage III adenomyosis remains low, and this severe stage of adenomyosis is characterized as the uterine factor of infertility. Conclusion. Stage I adenomyosis is not the cause of infertility or IVF failures, and does not require pre-treatment. At stages II-III adenomyosis pre-treatment improves the effectiveness of IVF programs.
Palavras-chave
Texto integral
Sobre autores
Artem Aksenenko
Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: a_axenenko@oparina4.ru
gynecologist of the 1st Gynecology Department
Alexandr Gus
Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: a_gus@oparina4.ru
Dr. Med. Sci., Professor, Head of the Department Ultrasound Diagnostic Imaging
Nona Mishieva
Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: nondoc555@mail.ru
PhD, Senior Researcher of the 1st Gynecology Department
Daria Senina
Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: seninadashal995@gmail.ru
clinical resident
Bibliografia
- Benagiano G, Habib a M., Brosens I. The pathophysiology of uterine adenomyosis: an update. Fertil. Steril. 2012; 98(3): 572-9. https://dx.doi.org/10.1016/j.fertnstert.2012.06.044.
- Atabekoglu C.S., §ukur Y.E., Kalafat E., Ozmen B., Berker B., Aytag R., Sonmezer M. The association between adenomyosis and recurrent miscarriage. Eur. J. Obstet. Gynecol. Reprod. Biol. 2020; 250: 107-11. https://dx.doi.org/10.1016/j.ejogrb.2020.05.006.
- Buggio L, Monti E., Gattei U., Dridi D., Vercellini P. Adenomyosis: fertility and obstetric outcome. A comprehensive literature review. Minerva Ginecol. 2018; 70(3): 295-302. https://dx.doi.org/10.23736/S0026-4784.17.04163-6.
- Tamura H, Kishi H., Kitade M., Asai-Sato M., Tanaka A., Murakami T., Minegishi T., Sugino N. Clinical outcomes of infertility treatment for women with adenomyosis in Japan. Reprod. Med. Biol. 2017; 16(3): 276-82. https://dx.doi.org/10.1002/rmb2.12036.
- Liang Z., Yin M., Ma M., Wang Y., Kuang Y. Effect of pretreatment with a levonorgestrel-releasing intrauterine system on IVF and vitrified-warmed embryo transfer outcomes in women with adenomyosis. Reprod. Biomed. Online. 2019; 39(1): 111-8. https://dx.doi.org/10.1016/j.rbmo.2019.03.101.
- Benagiano G., Brosens I., Habiba M. Adenomyosis: a life-cycle approach. Reprod. Biomed. Online. 2015; 30(3): 220-32. https://dx.doi.org/10.1016/j.rbmo.2014.11.005.
- Yen C.F, Huang S.J., Lee C.L., Wang H.S., Liao S.K. Molecular characteristics of the endometrium in uterine adenomyosis and its biochemical microenvironment. Reprod. Sci. 2017; 24(10): 1346-61. https://dx.doi.org/10.1177/1933719117691141.
- Garavaglia E., Audrey S., Annalisa I., Stefano F., Iacopo T., Laura C., Massimo C. Adenomyosis and its impact on women fertility. Iran. J. Reprod. Med. 2015; 13(6): 327-36.
- Корсак В.С., ред. Регистр ВРТ РАРЧ. Отчет за 2018 год. Санкт-Петербург; 2020. 55с. [Korsak V.S., ed. Register of ART RARCH. Report for 2018. St. Petersburg, 2020. 55 p. (in Russian).
- Wu F., Liu F., Guan Y., Du J., Tan J., Lv H. et al. A nomogram predicting clinical pregnancy in the first fresh embryo transfer for women undergoing in vitro fertilization and intracytoplasmic sperm injection (IVF/ICSI) treatments. J. Biomed. Res. 2019; 33(6): 422-9.
- Seshadri S., Sunkara S.K. Natural killer cells in female infertility and recurrent miscarriage: a systematic review and meta-analysis. Hum. Reprod. Update. 2014; 20(3): 429-38. https://dx.doi.org/10.1093/humupd/dmt056.
- Moore J., Kennedy S., Prentice A. Modern combined oral contraceptives for pain associated with endometriosis. Cochrane Database Syst. Rev. 2000; (2): CD001019. https://dx.doi.org/10.1002/14651858.CD001019.
- Адамян Л.В., Кулаков В.И., Андреева Е.Н. Эндометриозы. Руководство для врачей. М.: Медицина; 2006. 416с. [Adamyan L.V., Kulakov V.I., Andreeva E.N. Endometriosis: A Guide for Physicians. M.: JSC "Publishing house Medicine", 2006. 416 р. (in Russian)].
- Younes G., Tulandi T. Effects of adenomyosis on in vitro fertilization treatment outcomes: a meta-analysis. Fertil. Steril. 2017; 108(3): 483-90. https://dx.doi.org/10.1016/j.fertnstert.2017.06.025.
- Bourdon M., Santulli P., Oliveira J., Marcellin L., Maignien C., Melka L. et al. Focal adenomyosis is associated with primary infertility. Fertil. Steril. 2020; 114(6): 1271-7. https://dx.doi.org/10.1016/j.fertnstert.2020.06.018.
- Mavrelos D., Holland T.K., O’Donovan O., Khalil M., Ploumpidis G., Jurkovic D., Khalaf Y. The impact of adenomyosis on the outcome of IVF-embryo transfer. Reprod. Biomed. Online. 2017; 35(5): 549-54. https://dx.doi.org/10.1016/j.rbmo.2017.06.026.
- Демидов В.Н., Гус А.И., Адамян Л.В., Хачатрян А.К. Эхография органов малого таза у женщин. Вып. 1. Эндометриоз. Практическое пособие. М.: ИИФ «Скрипто»; 1997. 60с. [Demidov V.N., Gus A.I., Adamyan L.V., Khachatryan A.K. Echography of the pelvic organs in women. Endometriosis: A Practical Guide. M.: "Scripto", 1997. 60 p. (in Russian)].
- Campbell S. Ultrasound evaluation in female infertility: Part 2: The uterus and implantation of the embryo. Obstet. Gynecol. Clin. North Am. 2019; 46(4): 697713. https://dx.doi.org/10.1016/j.ogc.2019.08.002.
Arquivos suplementares
